- letzte 200 News
- Archiv
| Zeit | Aktuelle Nachrichten | Rating | Leser | ||
|---|---|---|---|---|---|
| Di | Ainos, Inc.: A Partner Pays for VELDONA, and Ainos Keeps the Platform | 328 | VASRO has published an update report on Ainos, Inc. (NASDAQ: AIMD) following the company's VELDONA licence announcement of 24 September 2026 and its filing of 28 September. Ainos has granted BioPhoenix... ► Artikel lesen | ||
| 16.09. | Ainos Inc: A Front-End Customer Starts Ordering, and the Dataset Passes a Billion | 390 | VASRO has published an update report on Ainos, Inc. following the company's announcement of 14 September 2026. Two facts arrived in the same release. Ainos says it is receiving initial commercial orders... ► Artikel lesen | ||
| 11.09. | Ainos, Inc.: Three Patents Approved in Japan, and a Dataset Gathering Pace | 610 | VASRO has published an update report on Ainos, Inc. following two company announcements: a dataset milestone on 13 August and three Japanese robotics patents on 9 September. Both announcements measure... ► Artikel lesen | ||
| 07.09. | Baladna: The Capital Is Raised, Algeria Is Building - VASRO Reiterates BUY at QAR 2.33 | 533 | VASRO GmbH has published an update report on Baladna Q.P.S.C. (Qatar Stock Exchange: BLDN), reiterating its BUY recommendation with a target price of QAR 2.33 per share, revised from QAR 2.43 at initiation.... ► Artikel lesen | ||
| 07.09. | Sirnaomics Ltd.: Every Approved siRNA Drug Works in the Liver. This One Was Injected Into Skin Cancer. VASRO Initiates Coverage With BUY | 516 | VASRO GmbH has initiated coverage of Sirnaomics Ltd. (HKEX: 2257) with a BUY recommendation and a target price of HK$7.07 per share. Sirnaomics develops siRNA medicines, drugs that silence a disease-causing... ► Artikel lesen | ||
| 31.08. | Zaptec ASA: Europe's Largest AC Charging Brand, With the Service Layer Priced at Zero - VASRO Initiates Coverage With BUY | 965 | VASRO has initiated equity research coverage of Zaptec ASA (Oslo Børs: ZAP) with a BUY recommendation and a target price of NOK 72.00 per share. Against the NOK 50.30 close of 28 August 2026, the valuation... ► Artikel lesen | ||
| 12.08. | Spinneys 1961 Holding PLC: The Estate Grew 17%, Demand Did Not - First Half 2026 Update | 656 | VASRO has published an update report on Spinneys 1961 Holding PLC following the company's first-half 2026 results. The central message is not that the growth story has broken. It has not. The more important... ► Artikel lesen | ||
| 07.08. | Ainos, Inc.: 613 Million Records, and a Cost Base That Did Not Move - First Half 2026 Update | 538 | VASRO has published an update report on Ainos, Inc. following the company's first-half 2026 results. The central message is not that financial scale has arrived. It has not. The more relevant development... ► Artikel lesen | ||
| 05.08. | Baladna: From Qatar Dairy Leader to Regional Food-Security Platform | 708 | VASRO has initiated equity research coverage of Baladna Q.P.S.C. with a BUY recommendation and a target price of QAR 2.43 per share. Compared with the QAR 1.21 ex-rights reference price, the valuation... ► Artikel lesen | ||
| 05.08. | Luberef Reports Record H1 2026 Earnings as Base Oil Margins Drive Cash Flow and Higher Valuation | 803 | VASRO has published an updated equity research report on Saudi Aramco Base Oil Company - Luberef, maintaining its BUY recommendation and raising the target price from SAR 136.00 to SAR 158.00 per share.... ► Artikel lesen | ||
| 22.06. | Ainos, Inc.: AI Nose Starts Reading the Breath Itself in New Emergency-Medicine Study at National Taiwan University | 617 | VASRO has published an update report on Ainos, Inc. following the company's announcement of a one-year research program with National Taiwan University. The report, titled "AI Nose Starts Reading the... ► Artikel lesen | ||
| 05.06. | Ainos, Inc.: AI Nose Enters Live Hospital Emergency-Room Deployment at NTUH | 826 | VASRO has published an update report on Ainos, Inc. following the company's announcement of an IRB-approved research program with National Taiwan University Hospital. The report, titled "AI Nose Enters... ► Artikel lesen | ||
| 25.05. | Saudi Aramco Base Oil Company - Luberef: Q1 Confirms Earnings Resilience and Growth II Progress - VASRO Reiterates BUY | 1.291 | VASRO has published an update report on Saudi Aramco Base Oil Company - Luberef following the company's Q1 2026 results. The core investment message is unchanged: Luberef remains a focused base-oils... ► Artikel lesen | ||
| 19.05. | Ainos, Inc.: AI Nose Builds Broader Operating Footprint Across Semiconductors and Healthcare | 772 | The report, titled "AI Nose Builds a Broader Operating Footprint Across Semiconductors and Healthcare," reviews Ainos' Q1 2026 progress and frames the quarter as a build-out phase for the company's... ► Artikel lesen | ||
| 14.05. | Spinneys 1961 Holding PLC: Demand Quality Holds Despite March Logistics Shock - VASRO Reiterates BUY | 723 | VASRO has published an update report on Spinneys 1961 Holding PLC following the company's Q1 2026 results. The core investment message is unchanged: demand quality remains strong, the operating platform... ► Artikel lesen | ||
| 16.04. | Ainos Inc.: AI Nose Deployment in Hospital Infrastructure Marks Transition to Scalable Multi-Domain Platform | 867 | VASRO's latest update on Ainos Inc. focuses on a new operational milestone that materially strengthens the company's platform thesis. Through a partnership with MacKay Memorial Hospital and Topco Scientific... ► Artikel lesen | ||
| 07.04. | Saudi Aramco Base Oil Company - Luberef Initial Report | 677 | initiated. In VASRO's initial equity report, Luberef is framed as a focused base oils platform rather than a generic energy exposure. The core point is straightforward: even through a softer FY2025... ► Artikel lesen | ||
| 01.04. | Spinneys Update - Core Operations Intact; Regional Volatility Not Yet Showing an Operating Break | 565 | tracked. This update is not arguing that the regional backdrop is easy; it is arguing that Spinneys' operating story has not visibly broken. Since the FY2025 release, the company's official follow-up... ► Artikel lesen | ||
| 01.04. | Ainos Update - FY2025 and the 10-K Add Structure to 2026 AI Nose Execution | 569 | tracked. This update does not introduce a new thesis; it gives the existing one more structure. FY2025 revenue rose to USD 124,157, gross profit turned positive at USD 102,911, gross margin reached... ► Artikel lesen | ||
| 24.02. | Ainos Update - Ainos and ASE: Deposit Received; Phase-One Delivery Targeted (Q2 2026) | 702 | This update is about execution credibility-moving from "roadmap language" to hard markers that can be tracked. In VASRO's initiating coverage, ASE was framed as the industrial anchor customer for AI... ► Artikel lesen | ||
| 18.02. | Ainos Update - What We Learn from the VELDONA FCGS Interim Readout | 720 | This update is a clinical signal calibration note. Ainos reported interim results from an ongoing open-label, multi-dose study of VELDONA (low-dose oral interferon alpha) in Feline Chronic Gingivostomatitis... ► Artikel lesen | ||
| 16.02. | Spinneys Update - FY2025 Delivery + 2026 Guidance: Store Rollout, Digital Penetration, and Margin Architecture | 740 | This update report is a performance and forward-path calibration. It takes Spinneys' latest full-year disclosure set and answers the only questions that matter for a scaled grocery operator: Did the... ► Artikel lesen | ||
| 05.02. | Spinneys 1961 Holding PLC (Dubai Financial Market: SPIN) - Initial Equity Report (Non-Rated) | Premium Fresh-Led Grocery + Scalable Expansion Playbook | 669 | This initiating report is designed to do one thing well: translate Spinneys from a "known brand" into a trackable operating equity narrative that investors and internal decision-makers can underwrite.... ► Artikel lesen | ||
| 03.02. | Ainos Update - AI Nose Expands into Robotic Sensing for Inspection & Safety Monitoring (Mirle Automation Partnership) | 769 | This update isolates a specific operational development: Ainos announced a technology partnership with Mirle Automation Corporation to integrate AI Nose into mobile and quadruped robotic platforms,... ► Artikel lesen | ||
| 20.01. | Ainos, Inc. (NASDAQ: AIMD) - Initial Equity Report (Non-Rated) | Two Engines: AI Nose Execution + VELDONA Clinical Gates | 700 | This initiating publication is built to do one job: turn Ainos into a monitorable equity narrative with clear execution gates, instead of a "story stock" people talk about but cannot underwrite. VASRO... ► Artikel lesen |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.